Skinvisible Brings Patented Technology to the Topical and Transdermal Cannabis Industry

Invisicare Delivery System to Enhance Medical and Recreational Marijuana Product Lines

LAS VEGAS, NV / ACCESSWIRE / February 21, 2017 / Skinvisible Pharmaceuticals, Inc. (SKVI), developers of over 40 topical prescription (Rx), over-the-counter (OTC) and cosmeceutical products using its patented Invisicare® polymer delivery systems, announces it has now additionally developed topical and transdermal cannabis products from hemp-derived CBD, with its next developments to include cannabinoids from marijuana (CBD and THC).

“Our research shows that Invisicare formulations have a much greater release of active ingredients than products in the marketplace, they resist wash-off and rub-off while still allowing the skin to breathe naturally. In addition to these great benefits, it is our belief that our 15 plus years of topical product development experience, as well as our 14 technology and product patents, will stand-out in the cannabis

... read more at: